hmvod Limited — Board/Management Information 2002

Nov 29, 2002

The Stock Exchange of Hong Kong Limited takes no responsibility for the contents of this announcement, makes no representation as to its accuracy or completeness and expressly disclaims and liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

This announcement, for which the directors of the Company collectively and individually accept full responsibility, includes particulars given in compliance with the Rules Governing the Listing of Securities on the Growth Enterprise Market of The Stock Exchange of Hong Kong Limited for the purpose of giving information with regard to the Company. The directors of the Company, having made all reasonable enquiries, confirm that, to the best of their knowledge and belief: (1) the information contained in this announcement is accurate and complete in all material respects and not misleading; (2) there are no other matters the omission of which would make any statement in this announcement misleading; and (3) all opinions expressed in this announcement have been arrived at after due and careful consideration and are founded on bases and assumptions that are fair and reasonable.

Systek Information Technology (Holdings) Limited

訊 泰 科 技（控 股）有 限 公 司 *

(incorporated in the Cayman Islands with limited liability)

APPOINTMENT OF AN INDEPENDENT NON-EXECUTIVE DIRECTOR

AND A MEMBER OF AUDIT COMMITTEE

With reference to the announcement dated 6 November 2002 regarding the resignation of The Hon. Dr. Wong, Yu Hong Philip from an independent non-executive director and a member of the audit committee of the Company, the board of directors (the “Board”) of Systek Information Technology (Holdings) Limited (the “Company”) is pleased to announce that Dr. Albert Wong has been appointed as an independent non-executive director and a member of audit committee of the Company in place of The Hon. Dr. Wong, Yu Hong Philip with effect from 30 November 2002. Accordingly, with effect from 30 November 2002, the Board consists of two independent non-executive directors and the audit committee consists of two members in compliance with the requirements of Rules 5.05 and 5.23 of the Rules Governing the Listing of Securities on the Growth Enterprise Market of the Stock Exchange of Hong Kong Limited.

Dr. Albert Wong, aged 55, received his doctorate in Pharmaceutics in 1980 from the University of Wisconsin. During his tenure in the USA, he was a senior scientist at Eli Lilly and Syntex Research where he developed a number of novel pharmaceutical and cosmetic products and was granted several patents for his inventions. After Dr. Wong returned to Hong Kong in 1995, he founded, Medicon Pharmaceutical Consultancy, PAC BioSciences Consultants Limited and Zigen Pharmaceutical Ltd., which specialize in the commercialization of Chinese medicine and sales of premium quality Chinese medicines to international markets. Dr. Wong also founded The Modernized Chinese Medicine International Association, a professional association which promotes the modernization of Chinese medicine. Furthermore, Dr. Wong was a member of the Vetting Committee of the Innovation and Technology Fund (Biotechnology Projects) of Innovation and Technology Commission, HKSAR in 2000.

The Board would like to take this opportunity to welcome Dr. Wong to the Board.

By Order of the Board

To, Cho Kei

Chairman

Hong Kong, 29 November 2002

This announcement will remain on the GEM website www.hkgem.com on the “Latest Company Announcements” page for at least 7 days from the day of its posting and on the website of the Company at www.systekit.com.hk.

* for identification purpose only